Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2007

Main Data: 31/12 Year 2007
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 454.45
– gross industrial income 188.59
– total operating cost 118.95
– operating profit 69.64
– net financial expenses 7.71
– group profit 39.46

 

Consolidated balance sheet Millions/Euro
– working capital 70.71
– non-current assets 147.86
– provision for indemnities and other provisions – 21.60
– net debt – 86.61
– equity pertaining to the group and minority interests 110.36

 

Other information Millions/Euro
– depreciation, amortization and impairment 11.05
– R & D costs 22.18

 

  Euro
Dividend per share  0.85

 

  No.
Employees 2,629

 

  Euro
Share capital 17,732,000

 

Main Data: 30/06 Year 2007
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 209.6
– gross industrial income 87.1
– total operating cost 62.8
– operating profit 24.3
– net financial expenses 3.7
– group profit 11.3

 

Consolidated balance sheet Millions/Euro
– working capital 81.1
– non-current assets 144.9
– provision for severance indemnities and other provisions – 29.5
– net debt – 109.0
– equity pertaining to the group and minority interests 87.5

 

Other information Millions/Euro
– depreciation, amortization and impairment 5.5
– R & D costs 11.2

 

  No.
Employees 2,731

 

  Euro
Shares capital 18,772,000

 

Net sales by Sector: Year 2007  
  Millions/Euro  
 tea, herbs & coffee  77.07  17.0%
 pharmaceuticals packaging  248.53  54.6%
 pharmaceuticals processing  128.85  28.4%
 Total  454.45  100.0%

 

Net sales by Country: Year 2007
  Millions/Euro  
E.U. (excluding Italy) 183.46 40.4%
Other European countries 41.96 9.2%
North America 89.40 19.7%
Asia & Middle East 67.15 14.8%
Other countries 36.72 8.1%
Total exports 419.09 92.2%
Italy 35.36 7.8%
Total 454.45 100.0%